MARVELD2 and cancer: This suggests that TRiC plays a potential role in cancer cell development by direct modulation of the folding and activity for client proteins related to oncogenesis, such as tumor suppressor Von Hippel-Lindau (VHL) [14,60] and p53 [12,61] as well as the pro-oncogenic protein STAT3 [10].